KLF4 translation level is associated with differentiation stage of different pediatric leukemias in both cell lines and primary samples

Clinical and Experimental Medicine

Volumn 13, Issue 2, 2013, Pages 99-107

  Guo, Xiaoping ^a   Tang, Yongmin ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Differentiation stage; Expression; Kr ppel like factor 4 (KLF4); Leukemia

Indexed keywords

CD34 ANTIGEN; KRUPPEL LIKE FACTOR 4; MESSENGER RNA;

ADOLESCENT; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CHILD; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HUMAN; INFANT; KARYOTYPE; LEUKEMIA CELL LINE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME;

ADOLESCENT; ANTIGENS, CD34; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INFANT; K562 CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LEUKEMIA; MALE; NEOPLASM STAGING; PROGNOSIS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; RNA, NEOPLASM; SEVERITY OF ILLNESS INDEX; TUMOR MARKERS, BIOLOGICAL; U937 CELLS;

EID: 84877756278     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-012-0187-4     Document Type: Article

References (26)

1. Cullingford TE, Butler MJ, Marshall AK et al (2008) Differential regulation of Kruppel-like factor family transcription factor expression in neonatal rat cardiac myocytes: effects of endothelin-1, oxidative stress and cytokines. Biochim Biophys Acta 1783:1229-1236
2. Fruman DA, Ferl GZ, An SS et al (2002) Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes. Proc Natl Acad Sci USA 99:359-364
3. Evans PM, Liu C (2008) Role of Krüppel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim Biophys Sin (Shanghai) 40:554-564
4. Schuetz A, Nana D, Rose C et al (2011) The structure of the Klf4 DNA-binding domain links to self-renewal and macrophage differentiation. Cell Mol Life Sci 68:3121-3131
5. Katz JP, Perreault N, Goldstein BG et al (2012) The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129:2619-2628
6. Zhao W, Hisamuddin IM, Nandan MO et al (2004) Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 23:395-402
7. Wei D, Gong W, Kanai M et al (2005) Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 65:2746-2754
8. Ohnishi S, Ohnami S, Laub F et al (2003) Downregulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem Biophys Res Commun 308:251-256
9. Pandya AY, Talley LI, Frost AR et al (2004) Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin Cancer Res 10:2709-2719
10. Chen YJ, Wu CY, Chang CC et al (2008) Nuclear Krüppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis. Cancer Biol Ther 7:777-782
11. Kharas MG, Yusuf I, Scarfone VM et al (2007) KLF4 suppresses transformation of pre-B cells by ABL oncogenes. Blood 109:747-755
12. Yasunaga J, Taniguchi Y, Nosaka K et al (2004) Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res 64:6002-6009
13. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:45
14. Witte KE, Ahlers J, Schäfer I et al (2011) High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia. Pediatr Hematol Oncol 28:91-99
15. Ebinger M, Witte KE, Ahlers J et al (2010) High frequency of immature cells at diagnosis predicts high minimal residual disease level in childhood acute lymphoblastic leukemia. Leuk Res 34:1139-1142
16. Van Rhenen A, Feller N, Kelder A et al (2005) High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clin Cancer Res 11:6520-6527
17. Zhu X, Hart R, Chang MS et al (2004) Analysis of the major patterns of B cell gene expression changes in response to short-term stimulation with 33 single ligands. J Immunol 173:7141-7149
18. Van Zelm MC, van der Burg M, de Ridder D et al (2005) Ig gene rearrangement steps are initiated in early human precursor B cell subsets and correlate with specific transcription factor expression. J Immunol 175:5912-5922
19. Feinberg MW, Wara AK, Cao Z et al (2007) The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J 26:4138-4148
20. Kong Y, Yoshida S, Saito Y et al (2008) CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia 22:1207-1213
21. Kahng Jimin, Shin So-Young, Han Kyungja (2007) Proportions of cells expressing CD38-/CD34+, CD38+/CD34+, CD19+/CD34+, or CD13,33+/CD34+ in the regenerating bone marrows during complete remission of acute leukemia or after bone marrow transplantation. Korean J Lab Med 27:406-413
22. Van Grotel M, Van den Heuvel-Eibrink MM, Van Wering ER et al (2008) CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia. Pediatr Blood Cancer 51:737-740
23. Babusikova O, Stevulova L, Fajtova M (2009) Immunophenotyping parameters as prognostic factors in T-acute leukemia patients. Neoplasma 56:508-513
24. Marisavljevic D, Kraguljac-Kurtovic N (2010) Biological implications of circulating CD34 (+) cells in myelodysplastic syndromes. J Buon 15:753-757
25. Den Heuvel-Eibrink MMV, Der Holt BV, Burnett AK et al (2007) CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age. Ann Hematol 86:329-337
26. Yong AS, Rezvani K, Savani BN et al (2007) High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects. Blood 110:770-775